Issue 102, 2014

A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile

Abstract

Here we report a curcumin–artemisinin coamorphous solid (1 : 1) prepared by rotavaporization and a dramatic increase in the pharmacokinetic profile of curcumin (AUC0–12 2.6 μg h mL−1, Cmax 1 μg mL−1) administered as CUR–ART to SD rats. PXRD and FESEM analysis explains the molecular basis for the solubility enhancement of coamorphous CUR–ART.

Graphical abstract: A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile

Supplementary files

Article information

Article type
Communication
Submitted
07 Oct 2014
Accepted
28 Oct 2014
First published
29 Oct 2014

RSC Adv., 2014,4, 58357-58361

Author version available

A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile

K. Suresh, M. K. C. Mannava and A. Nangia, RSC Adv., 2014, 4, 58357 DOI: 10.1039/C4RA11935E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements